Details of the Drug

General Information of Drug (ID: DMU3HYY)

• Drug Name: EBV-CTL

Indication

Disease Entry	ICD 11	Status	REF
Post-transplant lymphoproliferative disorder	2B32	Phase 2	[1]

• Cross-matching ID: TTD ID: D0CG1A

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)